Please assess the completion status of the following clinical trial:

Trial Title: A Study of MK0359 in Patients With Chronic Asthma (0359-013)

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: CROSSOVER
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE2
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* You are between the ages of 18 and 45~* You have had a history for at least a year of COPD symptoms~* Your current asthma treatment is limited to short-acting beta-agonists(such as albuterol)~* You have a history of smoking one pack of cigarettes per day for 7 years~* You will not be away from home for more than 5 days during the study~Exclusion Criteria:~* You are unwilling to limit your alcohol use to less than 5 drinks per week~* You have been in a research study with an investigational drug or vaccine in the last 4 weeks~* You have donated blood in the last 4 weeks~* You have been hospitalized or had major surgery in the last 4 weeks~* You have been treated in the emergency room within the last 4 weeks or hospitalized within the last 3 months for your asthma~* You have a history of heart problems in the last 6 months~* You have a history of stomach problems~* You are unwilling to avoid grapefruit juice throughout the study

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 45 Years
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).